iBio (IBIO) Earnings Date & Reports

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IBIO is expected to report earnings to fall 8.86% to -6 cents per share on September 29

Q2'26

Est.

$-0.06

Q1'26

Beat

by $0.13

Q4'25

Beat

by $0.34

Q3'25

Beat

by $0.14

Q2'25

Missed

by $0.12

The last earnings report on May 12 showed earnings per share of -7 cents, beating the estimate of -20 cents. With 912.08K shares outstanding, the current market capitalization sits at 83.96M.

View a ticker or compare two or three

Compare

IBIO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for IBIO